Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-3-29
|
pubmed:abstractText |
Total body irradiation (TBI) is used therapeutically for treatment of leukemias and other malignancies of the hemopoietic system. Ionizing radiation produces oxygen free radicals that contribute to cytotoxicity. Breath collected from one patient undergoing therapeutic TBI showed measurable changes in levels of ethane during treatment. Breath ethane is a marker of lipid peroxidation of n-3 fatty acids. The TBI treatment involved 4 days of irradiation. The largest changes in breath ethane occurred on Day 2. The increased levels of breath ethane on Day 2 were correlated to clinical manifestations of toxicity. The correlation of the onset of gastrointestinal side effects with higher levels of breath ethane suggests that breath ethane may be a clinically useful measure of the toxicity of various TBI fractionation treatment protocols currently in use at different medical centers. The levels of breath ethane on the other days of treatment were lower, suggesting that the oxidative-antioxidative balance of the patient may be important in protection against free radical mediated injury. These results for a single patient suggest that breath ethane may be a promising approach to elucidate the role of antioxidants in clinical TBI and should be extended for verification to a larger volunteer patient population.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0891-5849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
569-76
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7867973-Adult,
pubmed-meshheading:7867973-Breath Tests,
pubmed-meshheading:7867973-Dose-Response Relationship, Radiation,
pubmed-meshheading:7867973-Ethane,
pubmed-meshheading:7867973-Free Radicals,
pubmed-meshheading:7867973-Humans,
pubmed-meshheading:7867973-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:7867973-Lipid Peroxidation,
pubmed-meshheading:7867973-Male,
pubmed-meshheading:7867973-Oxidative Stress,
pubmed-meshheading:7867973-Whole-Body Irradiation
|
pubmed:year |
1994
|
pubmed:articleTitle |
Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study.
|
pubmed:affiliation |
Division of Radiation Oncology, Johns Hopkins Medical Institutions, Baltimore, MD.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|